Pharmaglobe America Group, Inc. (``Pharmaglobe'') Announces Appointment Of New CEO andCFO


KELOWNA, British Columbia, July 12, 2004 (PRIMEZONE) -- Pharmaglobe America Group, Inc. (Pink Sheets:PMGA) is pleased to announce that Hannu Tukkimaki has been appointed as the new President & CEO of the Company and that Jonathan D. Andrews has been appointed as the Chief Financial Officer of the company.

About Hannu Tukkimaki, President & CEO

Hannu Tukkimaki comes from a 33-year career with TELUS Advanced Communications, the last seventeen years of which were as a Senior Customer Systems Engineer. Mr. Tukkimaki was active with TELUS in the areas of systems design, systems planning and financial structuring for TELUS' major national and international customers.

Mr. Tukkimaki originally joined Pharmaglobe, after retiring from TELUS, as Vice-President of Sales and Marketing. Now as President & CEO, he will continue to focus the Company's effort on helping the approximately 30 million non-insured Americans lower their prescription medication costs. The Company's sales and marketing section is now operational and includes a "Call Management Centre" for in-bound and out-bound calling with professional service and support people manning 1-800 lines and with fully licensed pharmacists on staff to provide professional consultation to customers.

About Jonathan D. Andrews, CFO

Jonathan D. Andrews, CA-IT/CISA, FCA (England & Wales) joins the company as CFO after a long career of more than 20 years in assurance services, including risk management in a variety of public and industry sectors including oil, airlines, general trading and financial institutions in the U.K., U.S., Canada, Middle East, South Africa and Bermuda.

Mr. Andrews was formerly CEO of NetLearn Services Inc. based in Victoria, B.C., where he specialized in the development of technology and privacy-related content. He has also been responsible for instructing MBA students in the strategic implementation and management of technology for Royal Roads University of Victoria, B.C. He is the author of various articles and educational content for the Canadian Institute of Chartered Accountants and the American Institute of Certified Public Accountants and regularly provides editorial input to the Information Systems and Control Association. Mr. Andrews' experience in public accounting and information technology will be of invaluable assistance to the Company, where he will be responsible for planning, co-ordination and control of financial operations on a group-wide basis.

About Pharmaglobe

Pharmaglobe's "Call Management Centre" is currently targeting the over 30 million Americans that lack adequate medical and prescription drug service. Americans can place orders for their prescriptions via a toll free number (1-877-DRUGS-99). Drug price comparisons are available at www.meds4mail.com or by calling the toll free telephone number 1-866-324-9691 or the toll free fax line 1-866-324-9629.

This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussion with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be forward-looking statements. Forward-looking statements are based on expectations, estimates and projections at the time the statements are made and involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Such factors include general economic and business conditions, the ability to acquire and develop specific projects, and the ability to fund operations and changes in consumer and business consumption habits and other factors over which America Pharmaglobe Group, Inc. has little or no control.


 Shares Outstanding:           65,570,580
 52 Week High / Low:      $0.76 / $0.0039
 Current Price:                     $0.13


 Corporate Office:     Landmark Square Two
                       609 - 1708 Dolphin Avenue
                       Kelowna, BC  V1Y 9S4

            

Contact Data